Litcius/Paper detail

<i>In silico</i> and <i>in vitro</i> evaluation of kaempferol as a potential inhibitor of the <scp>SARS‐CoV</scp>‐2 main protease (<scp>3CLpro</scp>)

Abbas Khan, Wang Heng, Yanjing Wang, Jingfei Qiu, Xiao-Yong Wei, Shaoliang Peng, Shoaib Saleem, Mazhar Khan, Syed Shujait Ali, Dong‐Qing Wei

2021Phytotherapy Research117 citationsDOIOpen Access PDF

Topics & Concepts

In silicoIn vitroProtease inhibitor (pharmacology)ProteaseKaempferolChemistryMicrobiologyBiologyVirologyBiochemistryEnzymeVirusFlavonoidGeneAntioxidantViral loadAntiretroviral therapySARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing
<i>In silico</i> and <i>in vitro</i> evaluation of kaempferol as a potential inhibitor of the <scp>SARS‐CoV</scp>‐2 main protease (<scp>3CLpro</scp>) | Litcius